"Acting Attorney General Todd Blanche stated that the rescheduling of marijuana 'allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information.' This marks a significant shift in the federal approach to medical marijuana."
"For decades, marijuana has been classified alongside heroin and LSD in Schedule I, which is reserved for drugs deemed to have no accepted medical use and a high potential for abuse. The new classification acknowledges the reality of state regulations and the legalization of medical marijuana in many states."
"The rescheduling does not immediately affect recreational marijuana, focusing instead on FDA-approved products and those under state medical licenses. This change is expected to ease the burdensome process researchers faced in obtaining Schedule I licenses for studying marijuana."
The Trump administration has announced a significant change in the classification of medical marijuana, moving it from Schedule I to Schedule III. This change allows for increased research on its safety and efficacy, providing better care for patients and more reliable information for doctors. The new policy applies only to FDA-approved marijuana products and those regulated under state medical licenses. The administration aims to strengthen medical research while maintaining strict federal controls, and the Drug Enforcement Agency will hold hearings on broader marijuana rescheduling in the future.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]